PMN
ProMIS Neurosciences Inc.
9.40$
-13.5%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -398.2% | -5,687.5% | -94,534.3% | -45,804.0% | -1,819,749.1% | -506,627.7% | -278,255.8% | -56,608.8% | -281,217.6% | – | – | – | |
| 4.3% | 27.6% | 247.9% | 53.6% | 1,404.5% | 712.1% | 1,005.0% | 278.5% | 185.2% | – | – | – | |
| 151.1% | 2,014.4% | 21,241.4% | 5,579.7% | 226,303.3% | 53,859.7% | 26,486.6% | 3,091.3% | 8,050.4% | – | – | – | |
| – | – | – | – | 308,231.9% | 53,859.7% | 26,486.6% | 8,460.4% | -56,854.9% | – | – | – | |
| -36.0% | -32.4% | 16,823.9% | -2,988.2% | 92,999.7% | 68,386.9% | 50,136.0% | -9,508.6% | 89,192.5% | – | – | – | |
| 0.6% | 0.0% | 129,558.7% | 0.0% | 1.6% | 9,040.4% | 6,943.5% | 36.7% | 32.7% | – | – | – | |
| -0.6% | -148.2% | -7.6% | -1.6% | -43.3% | -17.3% | -7,148.6% | 575.1% | -32.7% | – | – | – | |
| – | – | – | – | – | – | – | -9,854.5% | – | – | – | – | |
| – | – | – | – | 2,496,459.0% | 724,305.4% | 556,303.6% | 52,195.1% | 0.0% | – | – | – | |
| 366.3% | 9,010.3% | 87,437.5% | 53,663.2% | 1,967,142.6% | 446,084.4% | 244,973.5% | 153,655.8% | 107,222.2% | – | – | – | |
| 6.9% | 3,174.6% | -7,104.3% | 7,857.5% | 147,349.9% | -60,560.6% | -40,431.0% | 96,935.9% | -182,726.8% | – | – | – | |
| -472.3% | -5,687.5% | -94,534.3% | -45,804.0% | -1,819,749.1% | -506,627.7% | -285,199.4% | -56,645.5% | -281,250.3% | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.